EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines releaseKoung Jin Suh, Jong Seok Lee|Oncotarget|2017Cited by 46
AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)Koung Jin Suh, Keun‐Wook Lee|The Oncologist|2023Cited by 19